Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Enterprise Value: 2009-2012

Historic Enterprise Value for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Dec 2012 value amounting to $1.1 billion.

  • Lexicon Pharmaceuticals' Enterprise Value rose 635.71% to $1.1 billion in Q4 2012 from the same period last year, while for Dec 2012 it was $1.1 billion, marking a year-over-year increase of 429.20%. This contributed to the annual value of $267.0 million for FY2024, which is 28.76% down from last year.
  • Lexicon Pharmaceuticals' Enterprise Value amounted to $1.1 billion in Q4 2012, which was up 20.46% from $940.0 million recorded in Q3 2012.
  • Over the past 5 years, Lexicon Pharmaceuticals' Enterprise Value peaked at $1.1 billion during Q4 2012, and registered a low of -$52.5 million during Q1 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Enterprise Value value was $343.6 million (recorded in 2010), while the average stood at $448.3 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Enterprise Value slumped by 142.41% in 2010 and then spiked by 820.77% in 2011.
  • Lexicon Pharmaceuticals' Enterprise Value (Quarterly) stood at $141.6 million in 2009, then soared by 94.19% to $275.0 million in 2010, then tumbled by 44.03% to $153.9 million in 2011, then skyrocketed by 635.71% to $1.1 billion in 2012.
  • Its Enterprise Value stands at $1.1 billion for Q4 2012, versus $940.0 million for Q3 2012 and $847.6 million for Q2 2012.